Cited by 49

The DOI matches its Crossref record.

High glucose‐induced activation of the polyol pathway and changes of gene expression profiles in immortalized adult mouse Schwann cells IMS32

Sango, Kazunori, Suzuki, Takeshi, Yanagisawa, Hiroko, Takaku, Shizuka, Hirooka, Hiroko, Tamura, Miyuki, Watabe, Kazuhiko·2006·Journal of Neurochemistry

Abstract

We investigated the polyol pathway activity and the gene expression profiles in immortalized adult mouse Schwann cells (IMS32) under normal (5.6 m m) and high (30 and 56 m m) glucose conditions for 7–14 days in culture. Messenger RNA and the protein expression of aldose reductase (AR) and the intracellular sorbitol and fructose contents were up‐regulated in IMS32 under high glucose conditions compared with normal glucose conditions. By employing DNA microarray and subsequent RT–PCR/northern blot analyses, we observed significant up‐regulation of the mRNA expressions for serum amyloid A3 (SAA3), angiopoietin‐like 4 (ANGPTL4) and ecotropic viral integration site 3 (Evi3), and the down‐regulation of aldehyde reductase (AKR1A4) mRNA expression in the cells under high glucose (30 m m) conditions. The application of an AR inhibitor, SNK‐860, to the high glucose medium ameliorated the increased sorbitol and fructose contents and the reduced AKR1A4 mRNA expression, while it had no effect on mRNA expressions for SAA3, ANGPTL4 or Evi3. Considering that the exposure to the high glucose (≥ 30 m m) conditions mimicking hyperglycaemia in vivo accelerated the polyol pathway in IMS32, but not in other previously reported Schwann cells, the culture system of IMS32 under those conditions may provide novel findings about the polyol pathway‐related abnormalities in diabetic neuropathy.

Overview

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2006.03885.x

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Previous studies on hyperglycemia and Angptl4 expression used very high levels of glucose, much beyond those that occur in vivo in the CNS, even in diabetes.

    “Although it has been suggested that hyperglycemia might regulate Angptl4 expression [33], these previous studies were done with very high levels of glucose, much beyond those that occur in vivo in the CNS, even in diabetes.”

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 66

  1. 10.1016/S0925-4773(00)00293-8 · DOI
  2. 10.1016/S0021-9258(18)60566-6 · DOI
  3. 10.1016/j.molbrainres.2004.05.002 · DOI
  4. 10.1007/s001250050921 · DOI
  5. 10.1093/jnen/63.11.1144 · DOI
  6. 10.3109/13506120009146246 · DOI
  7. 10.2174/0929867033457368 · DOI
  8. 10.1161/hh2101.098613 · DOI
  9. 10.1097/00005072-199612000-00001 · DOI
  10. 10.1016/S0074-7742(02)50081-7 · DOI
  11. 10.1210/en.143.4.1213 · DOI
  12. 10.1016/0026-0495(86)90197-6 · DOI
  13. 10.1159/000016291 · DOI
  14. 10.1021/ac00268a010 · DOI
  15. 10.1111/j.1432-1033.1995.tb20408.x · DOI
  16. 10.1258/000456304322880005 · DOI
  17. 10.1128/MCB.20.16.5840-5846.2000 · DOI
  18. Huey P. U., 1998, Lipoprotein lipase is expressed in cultured Schwann cells and functions in lipid synthesis and utilization, J. Lipid Res., 39, 2135, 10.1016/S0022-2275(20)32468-8 · DOI
  19. 10.1016/S0009-2797(02)00193-X · DOI
  20. Kato K., 2003, Effect of high glucose and C‐peptide on proliferation and MAP kinase activity in cultured immortalized mouse Schwann (IMS32) cells, J. Peripher. Nerv. Syst. (Abstr.), 8, 183
  21. 10.1016/S0006-2952(99)00121-5 · DOI
  22. 10.1016/S1566-0702(01)00385-X · DOI
  23. 10.1016/0167-4838(89)90090-3 · DOI
  24. 10.1007/BF01011860 · DOI
  25. 10.1074/jbc.M004029200 · DOI · Paper page
  26. 10.1002/(SICI)1097-4547(19990715)57:2<280::AID-JNR14>3.0.CO;2-U · DOI
  27. 10.1016/S0002-9440(10)64285-X · DOI
  28. 10.1111/j.1432-1033.1995.1059g.x · DOI
  29. 10.1074/jbc.M107101200 · DOI
  30. Low P. A., 1999, Diabetic Neuropathy, 317
  31. 10.1016/S0169-328X(01)00009-2 · DOI
  32. 10.1002/med.10024 · DOI
  33. 10.1073/pnas.89.17.7949 · DOI
  34. Mizisin A. P., 2003, Textbook of Diabetic Neuropathy, 83
  35. Mizisin A. P., 1996, Polyol pathway and osmoregulation in JS1 Schwann cells grown in hyperglycemic and hyperosmotic conditions, Am. J. Physiol., 270, F90
  36. 10.1016/S0304-3940(97)00416-3 · DOI
  37. Nakamura J., 2003, Effect of bFGF on Schwann cell growth and diabetic neuropathy in rats, J. Peripher. Nerv. Syst. (Abstr.), 8, 188
  38. 10.1016/0925-4439(94)90022-1 · DOI
  39. 10.1016/S0074-7742(02)50071-4 · DOI
  40. 10.1007/s10038-005-0278-0 · DOI
  41. 10.1093/jnen/60.7.686 · DOI
  42. 10.1006/exnr.2000.7591 · DOI
  43. 10.1172/JCI4711 · DOI
  44. 10.1016/S0024-3205(02)02040-4 · DOI
  45. 10.1046/j.1460-9568.2003.03102.x · DOI
  46. 10.1016/S0167-4889(00)00087-2 · DOI
  47. 10.1042/0264-6021:3440007 · DOI
  48. 10.1002/jnr.10247 · DOI
  49. 10.1038/sj.bjp.0703328 · DOI
  50. 10.1016/S1044-7431(03)00096-4 · DOI
  51. 10.1006/bbrc.1995.2835 · DOI
  52. 10.2337/diabetes.54.8.2460 · DOI · Paper page
  53. 10.1093/oxfordjournals.jbchem.a021944 · DOI
  54. 10.1002/(SICI)1097-4547(19990815)57:4<495::AID-JNR9>3.0.CO;2-Y · DOI
  55. 10.1111/j.1530-0277.2004.tb03227.x · DOI
  56. 10.1016/1056-8727(94)00022-G · DOI
  57. 10.1021/bi00004a038 · DOI
  58. Tomlinson D. R., 1999, Diabetic Neuropathy, 330
  59. Vander Jagt D. L., 1992, Reduction of trioses by NADPH‐dependent aldo–keto reductases. Aldose reductase, methylglyoxal, and diabetic complications, J. Biol. Chem., 267, 4364, 10.1016/S0021-9258(18)42844-X · DOI
  60. 10.1182/blood-2002-08-2652 · DOI
  61. 10.1002/jnr.490410215 · DOI
  62. 10.1111/j.1529-8027.2001.01012.x · DOI
  63. 10.1046/j.1440-1789.2003.00478.x · DOI
  64. Yabe‐Nishimura C., 1998, Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications, Pharmacol. Rev., 50, 21, 10.1016/S0031-6997(24)01347-4 · DOI
  65. 10.1016/S0301-0082(03)00034-0 · DOI
  66. 10.1194/jlr.C200010-JLR200 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Sango, K., Suzuki, T., Yanagisawa, H., Takaku, S., Hirooka, H., Tamura, M., & Watabe, K.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2006-05-12
Volume
98
Issue
2
Pages
446-458
ISSN
  • 0022-3042
  • 1471-4159
Cited by
49
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review